These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6800027)

  • 21. [Treatment of hypercalcemia (author's transl)].
    Kleinknecht D
    Schweiz Rundsch Med Prax; 1977 Aug; 66(34):1061-4. PubMed ID: 142980
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypercalcemia and bone resorption in malignancy.
    Walls J; Bundred N; Howell A
    Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hypercalcemia--a hospital survey.
    Blomqvist CP
    Acta Med Scand; 1986; 220(5):455-63. PubMed ID: 3812029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hypercalcemia secondary to malignancy.
    Borja ER; Pugh RP
    Mo Med; 1974 Jan; 71(1):19-22. PubMed ID: 4273915
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
    Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management and prognostic significance of hypercalcemia in renal cell carcinoma.
    Chasan SA; Pothel LR; Huben RP
    Urology; 1989 Mar; 33(3):167-70. PubMed ID: 2521966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of severe hypercalcemia].
    Fuss M; Manderlier T; Corvilain J
    Acta Clin Belg; 1971; 26(5):262-78. PubMed ID: 4266277
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms and treatment for bone metastases.
    Clines GA; Guise TA
    Clin Adv Hematol Oncol; 2004 May; 2(5):295-302. PubMed ID: 16163196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Etiology and therapy of hypercalcemia].
    Fujita T
    Nihon Rinsho; 1992 Jan; 50 Suppl():404-9. PubMed ID: 1533694
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of malignancy-associated hypercalcemia].
    Endo I; Inoue D
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of hypercalcemia.
    Zawada ET; Lee DB; Kleeman CR
    Postgrad Med; 1979 Oct; 66(4):105-10, 113. PubMed ID: 158184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-induced hypercalcemia.
    Lumachi F; Brunello A; Roma A; Basso U
    Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bisphosphonates in malignant hypercalcemia and bone pain].
    Lamy O
    Rev Med Suisse Romande; 2004 Feb; 124(2):111-4. PubMed ID: 15095627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Milk-alkali syndrome and hypercalcemia: a case report.
    Hart M; Windle J; McHale M; Grissom R
    Nebr Med J; 1982 May; 67(5):128-30. PubMed ID: 7099298
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The medical treatment of primary hyperparathyroidism].
    Lo Cascio V; Rossini M; Bertoldo F
    Recenti Prog Med; 1993 Apr; 84(4):287-95. PubMed ID: 8488334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
    Weissglas M; Löwik C; Schamhart D; Theuns H; Kurth KH; Papapoulos S
    BJU Int; 2007 Jun; 99(6):1530-3. PubMed ID: 17428243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.